BIOPHARMA CREDIT PLC

Capital/Financing Update • Mar 13, 2023

National Storage Mechanism | Additional information

RNS Number : 6616S

BioPharma Credit PLC

13 March 2023

13 March 2023

BIOPHARMA CREDIT PLC

(the "Company")

STATEMENT REGARDING SILICON VALLEY BANK

Pharmakon Advisors, LP, ("Pharmakon"), the investment adviser of the Company, notes the recent news reports regarding Silicon Valley Bank (together with its UK subsidiary, collectively, "SVB") being placed in receivership by US regulators. The Company does not hold deposits or other investments in SVB. In addition, Pharmakon has consulted with all of the Company's borrowers and is pleased to reiterate that they also have no significant exposure to SVB.

-Ends-

Enquiries

Buchanan

David Rydell / Mark Court / Jamie Hooper / Henry Wilson

+44 (0) 20 7466 5000

biopharmacredit@buchanan.uk.com

Notes to Editors

BioPharma Credit PLC is London's only specialist debt investor to the life sciences industry and joined the LSE in March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.

LEI: 213800AV55PYXAS7SY24

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

STREANDAFDXDEFA